French startup E(ye)Brain, in collaboration with neurologists at La Pitié-Salpêtrière Hospital in Paris, has been working on a video-oculography measurement technology for early diagnosis of neurological diseases. The company has re…
Giffords Recovering Speech, May Attend April Shuttle Launch
The procedure to replace the skull section that was removed in Giffords’ craniectomy is planned sooner than expected. Medscape Medical News
FDA Recalls Triad Lubricating Jelly Packages Due to Infection Concerns
A class II recall issued on Triad lubricating jelly packages follows a recall last month of potentially contaminated alcohol swabs by the same company. Medscape Medical News
E(ye)Brain Launches Mobile Eye-Tracking Device for Early Neuro Diagnosis
French startup E(ye)Brain, in collaboration with neurologists at La Pitié-Salpêtrière Hospital in Paris, has been working on a video-oculography measurement technology for early diagnosis of neurological diseases. The company has recently announced that its Mobile Eye Brain Tracker will soon be hitting the market, probably in Europe and elsewhere, except for the United States where no FDA clearance has been given to the device. The company hopes that its technology will be validated for early diagnosis in a range of disorders, such as progressive supranuclear palsy, corticobasal degeneration, multiple sclerosis, and even Parkinson’s.
AMD Research Critical As Experts Question Reported Decline In Prevalence
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50, robbing an estimated 10 million Americans of their sight and independence. Recent publicized findings purport a decline in the prevalence of AMD, but some exper…
AMD Research Critical As Experts Question Reported Decline In Prevalence
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50, robbing an estimated 10 million Americans of their sight and independence. Recent publicized findings purport a decline in the prevalence of AMD, but some exper…